Clinical Trials Logo

Macular Degeneration clinical trials

View clinical trials related to Macular Degeneration.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 5

NCT ID: NCT02462889 Not yet recruiting - Clinical trials for Age-Related Macular Degeneration

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

PRO-CON
Start date: June 2015
Phase: Phase 2
Study type: Interventional

This is a prospective, single-blind, randomized study to evaluate intravitreal aflibercept injection (IAI) versus sham as prophylaxis against conversion to neovascular age-related macular degeneration (AMD) in "high-risk" subjects.

NCT ID: NCT02379169 Not yet recruiting - Clinical trials for Risk Factors for Age Related Macular Degeneration

Effects of Sea Buckthorn Oil and Lutein on Eye Health

SBEYE
Start date: February 2015
Phase: N/A
Study type: Interventional

Low macular pigment optical density has been associated with increased risk of age-related macular degeneration, an important cause of vision problems in the elderly population. Dry eye is multifactorial disease of tears and the ocular surface associated with symptoms of dryness, grittiness, burning and redness of eyes. The risk of dry eye increases with age. The aim is to investigate the effects of sea buckthorn oil complemented with lutein on eye health, specifically on the macula.

NCT ID: NCT01669447 Not yet recruiting - Clinical trials for Degeneration of Macula and Posterior Pole

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis

Start date: September 2012
Phase: Phase 4
Study type: Interventional

Significant difference in the parameter settings of early optical coherence tomography (OCT spectal domain) in patients with subfoveal neovascular membrane realacionada age after treatment with a single intravitreal injection of Lucentis.

NCT ID: NCT00813891 Not yet recruiting - Clinical trials for Macular Degeneration

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration

Start date: January 2009
Phase: Phase 4
Study type: Interventional

The purpose of the investigators study is to look at the visual outcomes of Ranibizumab injections in combination with photodynamic therapy for the treatment of neovascular age-related macular degeneration.

NCT ID: NCT00627718 Not yet recruiting - Clinical trials for Age-Related Macular Degeneration

Assessment of Macular Edema Using HRT Technique

Start date: April 2008
Phase: N/A
Study type: Interventional

Age Related Macular Degeneration (ARMD) is the most common cause of irreversible blindness in people of age 50 or older in the western populations. ARMD has two forms, the wet and the dry forms. The wet form is more serious and can lead to irreversible loss of vision. In the wet form of ARMD, new blood vessels grow under the retina. These blood vessels leak blood and fluid and cause the retina and the macula to swell. So the thickness of the macula increases. One of the key factors in the treatment of wet ARMD is early diagnosis and treatment to prevent complete visual loss. In this research, we are going to use a technique, called the Heidelberg retinal tomograph (HRT) to measure and compare the thickness of the macula in healthy controls and in patients suspected of having ARMD. HRT is a non-invasive imaging system that uses laser to measure the thickness of the macula. This allows us to come up with a quite simple and easy-to-use technique that helps us to diagnose wet ARMD early and treat it before visual acuity is completely lost.